四环医药(00460)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

00460 四环医药

已收盘 12-19 16:08:47

0.660

-0.010

-1.49%

最高0.670	最低0.650	成交量1,540万
今开0.650	昨收0.670	日振幅2.99%
总市值61.45亿	流通市值61.45亿	总股本93.10亿
成交额1,008万	换手率0.17%	流通股本93.10亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"00460","market":"HK","secType":"STK","nameCN":"四环医药","latestPrice":0.66,"timestamp":1734595727010,"preClose":0.67,"halted":0,"volume":15400000,"delay":0,"floatShares":9310000000,"shares":9310000000,"eps":-0.006232506,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.01,"latestTime":"12-19 16:08:47","open":0.65,"high":0.67,"low":0.65,"amount":10080200,"amplitude":0.029851,"askPrice":0.67,"askSize":1938000,"bidPrice":0.66,"bidSize":258000,"shortable":3,"etf":0,"ttmEps":-0.0043884995101164835,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734658200000},"adr":0,"listingDate":1288195200000,"adjPreClose":0.67,"dividendRate":0.030882,"openAndCloseTimeList":[[1734571800000,1734580800000],[1734584400000,1734595200000]],"volumeRatio":0.978411,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00460","defaultTab":"news","newsList":[{"id":"2492949574","title":"南向资金12月17日净卖出四环医药308.20万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2492949574","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492949574?lang=zh_cn&edition=full","pubTime":"2024-12-18 09:30","pubTimestamp":1734485410,"startTime":"0","endTime":"0","summary":"12月17日，南向资金减持四环医药308.20万股连续3日减持。截止当日收盘，港股通共持有四环医药81949.71万股，占流通股8.77%。四环医药近5个交易日下跌4.29%，港股通累计减持798.40万股；近20个交易日下跌2.90%，港股通累计减持1393.29万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218093110a1f7330e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218093110a1f7330e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1515","00460","BK1600","BK1191"],"gpt_icon":0},{"id":"2491659646","title":"四环医药12月16日主力资金流出118万元 连续5日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2491659646","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491659646?lang=zh_cn&edition=full","pubTime":"2024-12-16 16:16","pubTimestamp":1734336986,"startTime":"0","endTime":"0","summary":"12月16日, 四环医药股价跌1.47%，报收0.67元，成交金额1280万元，换手率0.20%，振幅2.94%，量比1.05。四环医药今日主力资金净流出118万元，连续5日净流出，上一交易日主力净流出655万元，今日环比减少81.98%。近一年数据显示，该股主力连续5日净流出后，次日下跌概率为40.00%，平均跌幅为2.66%。该股近5个交易日下跌5.63%，主力资金累计净流出1294万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入42万元，其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216161711a1f27a66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216161711a1f27a66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1191","BK1515","BK1600","00460"],"gpt_icon":0},{"id":"2491944631","title":"四环医药(00460)出现大手买入310万股，成交价$0.68，涉资210.8万","url":"https://stock-news.laohu8.com/highlight/detail?id=2491944631","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491944631?lang=zh_cn&edition=full","pubTime":"2024-12-16 13:25","pubTimestamp":1734326700,"startTime":"0","endTime":"0","summary":"[大手成交]四环医药(00460)在下午01:25出现大手买入，成交量为310万，成交价为港币$0.68，涉资210.8万。至目前为止，股价无升跌，今日最高价为$0.68，而最低价为$0.66，总成交量为1.479千万股，总成交金额港币$995.054万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145550868_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145550868_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAV2412166032/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1593","00460","BK1191","BK1515","BK1600"],"gpt_icon":0},{"id":"2490879399","title":"四环医药12月12日主力资金流出165万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2490879399","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490879399?lang=zh_cn&edition=full","pubTime":"2024-12-12 16:16","pubTimestamp":1733991395,"startTime":"0","endTime":"0","summary":"12月12日，四环医药股价收平报0.71元，成交金额1414万元，换手率0.22%，振幅2.82%，量比1.35。四环医药今日主力资金净流出165万元，连续3日净流出，上一交易日主力净流出252万元，今日环比减少34.52%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为50.00%，平均跌幅为2.95%。该股近5个交易日上涨2.94%，主力资金累计净流出268万元；近20日主力资金累计净流入523万元，其中净流入天数为9日。该股主力净额占比0.03%，港股市场排名2531/2652。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212161730a1e885c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212161730a1e885c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1600","BK1593","BK1191","00460"],"gpt_icon":0},{"id":"2490880524","title":"四环医药12月11日遭主力抛售252万元 环比增加135.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490880524","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490880524?lang=zh_cn&edition=full","pubTime":"2024-12-11 16:17","pubTimestamp":1733905021,"startTime":"0","endTime":"0","summary":"12月11日, 四环医药股价涨1.43%，报收0.71元，成交金额1154万元，换手率0.18%，振幅2.86%，量比1.19。四环医药今日主力资金净流出252万元，上一交易日主力净流出107万元，今日环比增加135.51%。该股近5个交易日上涨2.90%，主力资金累计净流出33万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入827万元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211161728ab6efb26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211161728ab6efb26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1600","BK1593","BK1191","00460"],"gpt_icon":0},{"id":"2490004462","title":"“第九届智通财经资本市场年会暨上市公司颁奖典礼”26项大奖揭晓：245家公司分获殊荣!","url":"https://stock-news.laohu8.com/highlight/detail?id=2490004462","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490004462?lang=zh_cn&edition=full","pubTime":"2024-12-11 12:31","pubTimestamp":1733891515,"startTime":"0","endTime":"0","summary":"2024年12月11日上午，“第九届智通财经资本市场年会暨上市公司颁奖典礼” 在深圳隆重开幕。“第九届智通财经上市公司评选”自2016年启动以来，已连续成功举办9届。接近岁末，在全球资本的版图中，港股市场再度成为焦点。截至11月底，南向资金已连续17个月净流入，年内净买入总额突破7300亿港元，创下10年新高。剔除重复获奖，本届上市公司颁奖典礼共有245家公司及其高管分享这些荣誉。评选期间，吸引了超过1000家港美股上市公司积极参与。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1223189.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01783","01598","02018","06122","01880","06633","01735","00826","02020","00291","01450","02100","01093","02171","00780","00799","00017","00855","01405","01117","00451","00268","01651","00798","01427","01471","02225","02137","02145","01378","00460","01121","09919","01083","02158","09896","06058","06677","01969","02105","06682","00003","01907","00552","01992","01519","02013","06680","06086"],"gpt_icon":0},{"id":"2490065451","title":"四环医药（0460.HK），一个中国医药企业的“转型”样本","url":"https://stock-news.laohu8.com/highlight/detail?id=2490065451","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490065451?lang=zh_cn&edition=full","pubTime":"2024-12-10 15:50","pubTimestamp":1733817019,"startTime":"0","endTime":"0","summary":"四环医药荣获“年度转型先锋企业”奖。","market":"hk","thumbnail":"https://img7.gelonghui.com/column/4.png","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/4.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/1459106","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1600","00460","BK1593","BK1191","BK1515"],"gpt_icon":0},{"id":"2490745685","title":"四环医药12月09日主力资金流入63万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2490745685","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490745685?lang=zh_cn&edition=full","pubTime":"2024-12-09 16:17","pubTimestamp":1733732231,"startTime":"0","endTime":"0","summary":"12月09日, 四环医药股价涨2.90%，报收0.71元，成交金额727万元，换手率0.11%，振幅2.90%，量比0.92。四环医药今日主力资金净流入63万元，连续3日净流入，上一交易日主力净流入190万元，今日环比减少66.84%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为33.33%，平均涨幅为2.81%。该股近5个交易日上涨1.43%，主力资金累计净流入9万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入1087万元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209161834a1dfded4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209161834a1dfded4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1600","BK1191","00460","BK1593","BK1515"],"gpt_icon":0},{"id":"2489447838","title":"南向资金12月5日净卖出四环医药348.00万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2489447838","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489447838?lang=zh_cn&edition=full","pubTime":"2024-12-06 09:30","pubTimestamp":1733448607,"startTime":"0","endTime":"0","summary":"12月5日，南向资金减持四环医药348.00万股连续3日减持。截止当日收盘，港股通共持有四环医药83146.20万股，占流通股8.90%。港股通减持金额前五个股分别为美团-W、腾讯控股、药明生物、快手-W、理想汽车-W。四环医药近5个交易日下跌1.45%，港股通累计增持199.60万股；近20个交易日下跌8.11%，港股通累计减持517.70万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206093029ab613534&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206093029ab613534&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","00460","BK1515","BK1600","BK1191"],"gpt_icon":0},{"id":"2487839775","title":"轩竹生物5年半创收1606万净亏19亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2487839775","media":"长江商报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487839775?lang=zh_cn&edition=full","pubTime":"2024-11-29 14:24","pubTimestamp":1732861440,"startTime":"0","endTime":"0","summary":"2019年至2021年，轩竹生物没有任何营收，公司分别净亏损3.62亿元、1.62亿元和4.62亿元。2022年，轩竹生物并无收入，公司KBP-3571于2023年6月获批后于2023年开始取得销售及分销开支，公司净亏损5.12亿元。2024年上半年，轩竹生物收入猛增至1603万元，净亏损1.11亿元。综合来看，近5年半来，轩竹生物收入约1606万元，净亏损19.1亿元。数据显示，截至2024年6月30日，轩竹生物总资产约12.5亿元，净资产约10.3亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2024-11-29/doc-incxtkps8703703.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1600","BK1191","BK1515","BK4570","00460","PPI","BK1593"],"gpt_icon":0},{"id":"2486098314","title":"四环医药分拆轩竹生物赴港IPO 阳光人寿保险等紧急退出股东行列","url":"https://stock-news.laohu8.com/highlight/detail?id=2486098314","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486098314?lang=zh_cn&edition=full","pubTime":"2024-11-28 22:22","pubTimestamp":1732803742,"startTime":"0","endTime":"0","summary":"11月25日，港交所官网显示，轩竹生物科技股份有限公司（简称“轩竹生物”）递交上市申请。作为港股上市公司四环医药（00460.HK）的子公司，以创新药为主营业务的轩竹生物持续亏损，像大部分创新药企业一样，高额的研发费用吞噬了利润，在今年5月科创板IPO折戟后，轩竹生物终于录得营收，再次转战港交所。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411283253999272.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1515","00460","BK1191","BK1593","BK1600"],"gpt_icon":0},{"id":"2486129518","title":"四环医药11月27日主力资金流入134万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2486129518","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486129518?lang=zh_cn&edition=full","pubTime":"2024-11-27 16:15","pubTimestamp":1732695318,"startTime":"0","endTime":"0","summary":"11月27日, 四环医药股价跌2.78%，报收0.70元，成交金额2203万元，换手率0.33%，振幅5.56%，量比1.60。四环医药今日主力资金净流入134万元，连续3日净流入，上一交易日主力净流入1198万元，今日环比减少88.81%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为40.00%，平均涨幅为2.81%。该股主力净额占比0.02%，港股市场排名219/2645。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127161526abe2b1f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127161526abe2b1f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1191","BK1600","00460","BK1515"],"gpt_icon":0},{"id":"2486814533","title":"轩竹生物转战港股：分拆自四环医药，上半年亏损超1亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486814533","media":"澎湃新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486814533?lang=zh_cn&edition=full","pubTime":"2024-11-27 16:01","pubTimestamp":1732694460,"startTime":"0","endTime":"0","summary":"同时，四环医药以总价约3.08亿元进一步收购轩竹生物约3.6177%的股权。轩竹生物股权结构从港股招股书，截至最后实际可行日期，四环医药透过其间接全资附属公司轩竹医药及海南四环于轩竹生物全部已发行股本中拥有约56.47%权益。2023年，轩竹生物收入2.9万元，2024年上半年收入1603万元。净利润方面，2022年、2023年和2024年上半年，轩竹生物净亏损分别为5.12亿元、3.01亿元、1.11亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127160313abe2ab13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127160313abe2ab13&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["07226","HSTECH","BK1600","BK1515","00460","HSCEI","BK1593","BK1191"],"gpt_icon":0},{"id":"2486862549","title":"一图解码：自四环医药分拆 轩竹生物转战港股IPO 亏损持续收窄","url":"https://stock-news.laohu8.com/highlight/detail?id=2486862549","media":"财华社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486862549?lang=zh_cn&edition=full","pubTime":"2024-11-27 10:25","pubTimestamp":1732674326,"startTime":"0","endTime":"0","summary":"11月25日，自四环医药（00460.HK）分拆的创新药子公司轩竹生物向港交所递交了招股书，计划在主板挂牌上市；由中金公司担任独家保荐人。而在此之前，轩竹生物曾尝试在科创板上市，但在2024年5月24日晚间宣布终止科创板IPO申请，如今转战港股IPO。","market":"other","thumbnail":"https://images.finet.hk/photoLib/title/202411_1/10561924-564d-426b-a1de-41e65fda8850.jpg","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202411_1/10561924-564d-426b-a1de-41e65fda8850.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/6746831653243c0b5baf1fa7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"finet_stock","symbols":["07226","BK1600","BK1515","YANG","BK1191","00460","HSCEI","BK1593","HSTECH"],"gpt_icon":0},{"id":"2486020752","title":"四环医药(00460)11月26日斥资696.4万港元回购1000万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2486020752","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486020752?lang=zh_cn&edition=full","pubTime":"2024-11-26 18:50","pubTimestamp":1732618228,"startTime":"0","endTime":"0","summary":"智通财经APP讯，四环医药(00460)发布公告，于2024年11月26日该公司斥资696.4万港元回购1000万股，回购价格为每股0.68-0.71港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1216141.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1600","00460","BK1593","BK1515","BK1191"],"gpt_icon":0},{"id":"2486802291","title":"放弃科创板，四环医药分拆“轩竹生物-B”逐鹿港交所","url":"https://stock-news.laohu8.com/highlight/detail?id=2486802291","media":"活报告","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486802291?lang=zh_cn&edition=full","pubTime":"2024-11-26 18:13","pubTimestamp":1732615980,"startTime":"0","endTime":"0","summary":"公司是主要关注消化系统疾病、肿瘤领域及NASH的生物医药公司。LiveReport获悉，2008年成立的轩竹生物科技股份有限公司于2024年11月25日在港交所递交上市申请，拟香港主板上市，这是该公司第1次递交上市申请，独家保荐人为中金。于2023年6月月，KBP-3571收到国家药监局的NDA批准并开始产生收入，于2023年及截至2024年6月30日止六个月分别为人民币29,000元及人民币1600万元，因此2024年上半年公司营收大幅增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/cj/2024-11-26/doc-incxktkk7488206.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159982","00460","BK1191","BK1600","BK1593","BK1515"],"gpt_icon":0},{"id":"2486104046","title":"四环医药11月26日获主力加仓1198万元 环比增加941.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486104046","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486104046?lang=zh_cn&edition=full","pubTime":"2024-11-26 16:16","pubTimestamp":1732608962,"startTime":"0","endTime":"0","summary":"11月26日, 四环医药股价涨7.46%，报收0.72元，成交金额2807万元，换手率0.43%，振幅10.45%，量比3.20。四环医药今日主力资金净流入1198万元，上一交易日主力净流入115万元，今日环比增加941.74%。该股近5个交易日上涨7.25%，主力资金累计净流入1047万元；近20日主力资金累计净流出936万元，其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126161619a25687cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126161619a25687cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1600","00460","BK1593","BK1515","BK1191"],"gpt_icon":0},{"id":"2486285560","title":"四环医药(00460)出现大手卖出220万股，成交价$0.72，涉资158.4万","url":"https://stock-news.laohu8.com/highlight/detail?id=2486285560","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486285560?lang=zh_cn&edition=full","pubTime":"2024-11-26 16:08","pubTimestamp":1732608480,"startTime":"0","endTime":"0","summary":"[大手成交]四环医药(00460)在下午04:08出现大手卖出，成交量为220万，成交价为港币$0.72，涉资158.4万。至目前为止，股价升7.463%，今日最高价为$0.74，而最低价为$0.67，总成交量为3.998千万股，总成交金额港币$2.806千万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180815142908927_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180815142908927_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAV2411265741/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1600","BK1515","00460","BK1191","BK1593"],"gpt_icon":0},{"id":"2486104755","title":"港股异动 | 四环医药(00460)尾盘涨近6% 拟分拆轩竹生物在港上市 两附属就减重药物达成独家授权合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2486104755","media":"智通财经","labels":["corporation","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486104755?lang=zh_cn&edition=full","pubTime":"2024-11-26 15:48","pubTimestamp":1732607316,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，四环医药尾盘涨近6%，截至发稿，涨4.48%，报0.7港元，成交额2026.1万港元。消息面上，四环医药公布，建议分拆轩竹生物于联交所主板独立上市其H股。截至11月25日，四环医药间接拥有轩竹生物56.47%股份。按计划，于建议分拆及上市完成后，轩竹生物将仍为四环医药的附属公司。此外，四环医药近日公布，旗下非全资附属公司惠升生物与另一非全资附属公司渼颜空间达成独家授权合作，涉及惠升生物研发的用于减重的司美格鲁肽注射液。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1215924.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","BK1593","BK1600","BK1191","00460"],"gpt_icon":0},{"id":"2486694046","title":"四环医药(00460)上涨5.97%，报0.71元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2486694046","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486694046?lang=zh_cn&edition=full","pubTime":"2024-11-26 14:19","pubTimestamp":1732601963,"startTime":"0","endTime":"0","summary":"11月26日，四环医药(00460)盘中上涨5.97%，截至14:19，报0.71元/股，成交1704.37万元。四环医药控股集团有限公司是中国处方药市场的领先制药企业，主要业务为生产和销售心脑血管处方药物，自2007年起一直是全国最大的心脑血管处方药物供应商。公司的关键经营数据包括独特的销售模式、全国覆盖的销售网络、多元化的产品组合以及强大的研发能力。截至2024年中报，四环医药营业总收入9.5亿元、净利润-3342.4万元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/11/26141945682060.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1593","BK1515","BK1191","00460","BK1600"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sihuanpharm.com.cn","stockEarnings":[{"period":"1week","weight":-0.0563},{"period":"1month","weight":-0.029},{"period":"3month","weight":0.2885},{"period":"6month","weight":0.2642},{"period":"1year","weight":0.1395},{"period":"ytd","weight":0.0703}],"compareEarnings":[{"period":"1week","weight":-0.0144},{"period":"1month","weight":0.0147},{"period":"3month","weight":0.1028},{"period":"6month","weight":0.1018},{"period":"1year","weight":0.2035},{"period":"ytd","weight":0.1653}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"四环医药控股集团有限公司是一家主要从事研发、制造及销售医药产品和医美产品的投资控股公司。该公司通过三个分部运营其业务。医美产品分部包括填充类、塑形类、支撑类、补充类、光电设备类、体雕类、皮肤管理类及其他以及提供轻医美综合解决方案。创新药及其他药品分部从事研发及商业化糖尿病、乳腺癌、消化、肿瘤及非酒精性脂肪型肝炎等疾病领域的创新药。仿制药分部从事包括克林澳等仿制药的生产和销售。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.615385,"avgChangeRate":0.124205},{"month":2,"riseRate":0.571429,"avgChangeRate":0.002117},{"month":3,"riseRate":0.357143,"avgChangeRate":-0.025539},{"month":4,"riseRate":0.538462,"avgChangeRate":0.029608},{"month":5,"riseRate":0.384615,"avgChangeRate":-0.005384},{"month":6,"riseRate":0.538462,"avgChangeRate":-0.006997},{"month":7,"riseRate":0.538462,"avgChangeRate":-0.005865},{"month":8,"riseRate":0.461538,"avgChangeRate":-0.024169},{"month":9,"riseRate":0.153846,"avgChangeRate":-0.057211},{"month":10,"riseRate":0.615385,"avgChangeRate":0.038326},{"month":11,"riseRate":0.5,"avgChangeRate":0.015246},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.011561}],"exchange":"SEHK","name":"四环医药","nameEN":"SIHUAN PHARM"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"四环医药(00460)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供四环医药(00460)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"四环医药,00460,四环医药股票,四环医药股票老虎,四环医药股票老虎国际,四环医药行情,四环医药股票行情,四环医药股价,四环医药股市,四环医药股票价格,四环医药股票交易,四环医药股票购买,四环医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"四环医药(00460)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供四环医药(00460)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}